Log in
Enquire now
‌

US Patent 10927096 Ester substituted ion channel blockers and methods for use

Patent 10927096 was granted and assigned to Nocion Therapeutics on February, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Nocion Therapeutics
Nocion Therapeutics
Current Assignee
Nocion Therapeutics
Nocion Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10927096
Date of Patent
February 23, 2021
Patent Application Number
16815962
Date Filed
March 11, 2020
Patent Citations
‌
US Patent 10525143 Conjugate of polyethylene glycol and anesthetic, and preparation method thereof
‌
US Patent 10179116 Methods, compositions, and kits for treating pain and pruritis
Patent Citations Received
‌
US Patent 11332446 Charged ion channel blockers and methods for use
‌
US Patent 11643404 Ester substituted ion channel blockers and methods for use
0
‌
US Patent 11696912 Charged ion channel blockers and methods for use
0
‌
US Patent 11512058 Charged ion channel blockers and methods for use
‌
US Patent 11603355 Charged ion channel blockers and methods for use
Patent Primary Examiner
‌
Brenda L Coleman
Patent abstract

The invention provides compounds of Formula (I), or pharmaceutically acceptable salts thereof:

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10927096 Ester substituted ion channel blockers and methods for use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.